Download PDF
Erfahrungsheilkunde 2020; 69(05): 274-279
DOI: 10.1055/a-1252-5156
Praxis

Systemische Ozontherapie in der integrativen Onkologie

Simon Feldhaus
› Further Information
    Permissions and Reprints

Zusammenfassung

Bei der komplementären Behandlung onkologischer Patienten stellen sich besondere Herausforderungen. Dazu ist ein vernetzter und sehr individueller Behandlungsansatz im Sinne der integrativen Medizin zwingend. In unserem Zentrum ist die Ozontherapie zentraler Bestandteil der begleitenden onkologischen Therapie. Ozon wirkt gefäßerweiternd, verbessert das Fließverhalten des Blutes sowie die Verformbarkeit der Erythrozyten und verbessert so die Durchblutung. Es hat zudem schmerzlindernde und antientzündliche Wirkungen. Die komplementäre onkologische Behandlung mit ihrem ganzheitlichen Ansatz führt erfahrungsgemäß zu einem wesentlich verbesserten Allgemeinzustand der Patienten, reduziert die Nebenwirkungen von Chemotherapie und Bestrahlung und verbessert erheblich die Lebensqualität.

Der Autor nennt die wichtigsten Studien, erläutert die Anwendung der Ozontherapie und die möglichen Erfolge anhand einer Kasuistik aus seiner Praxis.

Abstract

The complementary treatment of oncological patients involves special challenges. This requires a networked and very individual treatment approach in the sense of integrative medicine. In our center, ozone therapy is a central component of the accompanying oncological therapy. Ozone has a vasodilatory effect, improves the rheological behavior of the blood as well as the deformability of the erythrocytes, and thus improves the blood circulation. It also has analgesic and anti-inflammatory effects. As experience shows, the complementary oncological treatment with its holistic approach leads to a significantly improved general condition of patients, reduces the side effects of chemotherapy and radiation, and significantly improves the quality of life.

The author names the most important studies and explains the application of the ozone therapy as well as the possible success with the help of a case history from his practice.

Schlüsselwörter

Ozon - Ozontherapie - Onkologie - integrative Onkologie

Key words

Ozone - ozone therapy - oncology - integrative oncology


Publication History

Article published online:
16 October 2020

© MVS Medizinverlage Stuttgart GmbH & Co. KG
Stuttgart · New York

 

  • Literatur

  • 1 Rubin MB. The history of ozone. The Schönbein Period, 1839–1868. Bull Hist Chem. 2001 Im Internet: http://www.scs.illinois.edu/~mainzv/HIST/awards/OPA%20Papers/2001-Rubin.pdf
    PubMedGoogle Scholar
  • 2 Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 2006; 37: 425-435
    CrossrefPubMedGoogle Scholar
  • 3 European Cooperation of Medical Ozone Societies EUROCOOP (Ärztliche Gesellschaft für Ozon-Anwendung in Prävention und Therapie). Information for patients. 2013 Im Internet: http://www.ozongesellschaft.de/information_for_patients_60.htm
    PubMedGoogle Scholar
  • 4 Sweet F, Kao MS, Lee SC. et al. Ozone selectively inhibits growth of human cancer cells. Science 1980; 209: 931-933
    CrossrefPubMedGoogle Scholar
  • 5 Karlic H, Kucera H, Metka M. et al. Effect of ozone and ionizing radiation on an in vitro model – A pilot study of 4 gynecologic tumors. Strahlenther Onkol 1987; 163: 37-42
    PubMedGoogle Scholar
  • 6 Zänker KS, Kroczek R. In vitro synergistic activity of 5-fluorouracil with low-dose ozone against a chemoresistant tumor cell line and fresh human tumor cells. Chemotherapy 1990; 36: 147-154
    CrossrefPubMedGoogle Scholar
  • 7 Enzelsberger H, Metka M, Salzer H. Effect of a parenteral ozone-oxygen mixture on the concentration of immunoglobulins (IgA, IgG, IgM), of vitamin A and lysozyme activity in patients with cervical cancer. Geburtshilfe Frauenheilkd 1987; 47: 343-345
    PubMedGoogle Scholar
  • 8 Parkhisenko I, Bil'chenko SV. The ozone therapy in patients with mechanical jaundice of tumorous genesis. Vestn Khir Im I I Grek 2003; 162: 85-87
    PubMedGoogle Scholar
  • 9 Subbotin VM, Zitta DV, Terekhina NA. Prophylaxis of acute postoperative gastroduodenal ulcers at the patients with colorectal cancer. Khirurgiia (Mosk) 2007; 3: 4-6
    PubMedGoogle Scholar
  • 10 Clavo B, Ceballos D, Gutierrez D. et al. Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy. J Pain Symptom Manage 2013; 46: 106-112
    CrossrefPubMedGoogle Scholar
  • 11 Tirelli U, Cirrito C, Pavanello M. et al. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue – A short report. Eur Rev Med Pharmacol Sci 2018; 22 (22) 8030-8033
    PubMedGoogle Scholar
  • 12 Clavo B, Santana-Rodríguez N, Llontop P. et al. Ozone therapy as adjuvant for cancer treatment: Is further research warranted?. Evid Based Complement Alternat Med. 2018 DOI: 10.1155/2018/7931849
    CrossrefPubMedGoogle Scholar
  • 13 Clavo B, Rodríguez-Esparragón F, Rodríguez-Abreu D. et al. Modulation of oxidative stress by ozone therapy in the prevention and treatment of chemotherapy-induced toxicity: Review and prospects. Antioxidants (Basel). 2019 DOI: 10.3390/antiox8120588
    CrossrefPubMedGoogle Scholar
  • 14 ISCO3 - International Scientific Committee of Ozonetherapy. Ozone Therapy and Its Scientific Foundations. Madrid: 2012 Im Internet: www.isco3.org
    PubMedGoogle Scholar
  • 15 Bucci B, Cannizzaro A, Brunetti E. et al. Ozone treatment inhibits proliferation in human neuroblastoma SK-N-SH cells. Rivista Italiana di Ossi geno-Ozonoterapia 2006; 5: 85-92
    PubMedGoogle Scholar
  • 16 Müller WJ. Klinische Studie über die Wirkung der Großen Eigenblutbehandlung mit Ozon auf die Befindlichkeit von Patienten mit Chronischem Müdigkeitssyndrom [Dissertation]. Rheinische Friedrich-Wilhelms-Universität Bonn; 2007. Im Internet: https://nbn-resolving.org/urn:nbn:de:hbz:5M-11394
    Google Scholar